Kenneth L. Waggoner

Kenneth L. Waggoner is Chief Executive Officer, President, General Counsel and Chairman of the board of PharmaCyte Biotech, Inc. He has almost four decades of experience in management, business, operations and law. Mr. Waggoner started his career as an attorney in private practice. Notably, he was a senior partner with Brobeck, Phleger and Harrison, named one of the top two law firms worldwide that provide services to biotechnology clients, including Chiron, Amgen, Biogen Idec, Sangamo, Ligand, DepoTech and many others. He was the Managing Partner of Brobeck’s Los Angeles office. Mr. Waggoner was also a member of the executive committee for almost 10 years and on the policy committee for numerous years managing Brobeck’s worldwide operations with annual revenues in excess of $750 million. While at Brobeck, Mr. Waggoner was the Co-Chairman of Brobeck’s worldwide Environmental Law Group. Further highlights of Mr. Waggoner’s career include leadership and legal positions with several startup companies during the last several years as well as working with Fortune 500 companies most of his professional career. During his tenure with Chevron, Mr. Waggoner served as the Vice President and General Counsel of its Global Downstream operations, where he was responsible for the overall management of legal services to the North American, Latin American, Europe and Asian Products Companies. At Chevron, he led a successful restructuring of the company’s international legal department following Chevron’s acquisition of Texaco. Mr. Waggoner received his Juris Doctorate with honors in 1973 from Loyola University School of Law in Los Angeles.